Mayne Pharma Group Ltd (ASX:MYX)
A$ 4.58 -0.05 (-1.08%) Market Cap: 389.64 Mil Enterprise Value: 279.18 Mil PE Ratio: 0 PB Ratio: 0.83 GF Score: 75/100

Half Year 2024 Mayne Pharma Group Ltd Earnings Call Transcript

Feb 25, 2024 / 10:00PM GMT
Operator

Thank you for standing by, and welcome to the Mayne Pharma Group Limited half year 2024 results call. (Operator Instructions) I would now like to hand the conference over to Mr. Shawn Patrick O'Brien, CEO. Please go ahead.

Shawn O;Brien
Mayne Pharma Group Ltd - Chief Executive Officer, Managing Director, Executive Director

' -

Thank you, operator. Hello, everyone, and thank you for joining us. As we discuss the first half of fiscal year '24 results. This provides us an opportunity to share the main transformation story to a higher margin growth business that operates on a lower level of net working capital than previously. With me on the call today is Aaron Gray, our CFO, Mayne Pharma Group.

On our next slide, the disclaimer slide, we were excited to share the results with you today. But as stated on the disclaimer slide, I want to emphasize that the information provided today's general nature and in summary, form only. It should be read in conjunction with the company's financial statements, which have been reviewed and signed off by BDO

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot